Nocardia asteroides-Induced movement abnormalities in mice: Relevance for Parkinson's disease?

Movement Disorders

Volumn 31, Issue 8, 2016, Pages 1134-1138

  Loeffler, David A ^a   LeWitt, Peter A ^b,c   Camp, Dianne M ^d  

^a Beaumont Hospital Royal   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CARBIDOPA; DOPAMINE; LEVODOPA; RNA 16S; UBIQUITIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HEREDITY; IN SITU HYBRIDIZATION; LEWY BODY; MOTOR DYSFUNCTION; MOUSE; NOCARDIA ASTEROIDES; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; THALAMUS; VIRUS ENCEPHALITIS; ANIMAL; BAGG ALBINO MOUSE; BRAIN; COMPLICATION; DIFFUSE LEWY BODY DISEASE; DISEASE MODEL; HUMAN; MACACA FASCICULARIS; METABOLISM; MICROBIOLOGY; NOCARDIOSIS; PATHOPHYSIOLOGY; PC12 CELL LINE; RAT;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; LEWY BODY DISEASE; MACACA FASCICULARIS; MICE; MICE, INBRED BALB C; MOVEMENT DISORDERS; NOCARDIA ASTEROIDES; NOCARDIA INFECTIONS; PARKINSON DISEASE; PC12 CELLS; RATS; RNA, RIBOSOMAL, 16S;

EID: 84978431681     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26711     Document Type: Article

References (39)

1. Houlden H, Singleton AB. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol 2012;124:325–338.
2. Tanner CM. Advances in environmental epidemiology. Mov Disord 2010;25(suppl 1):S58–S62.
3. Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol 2009;19:281–293.
4. Rail D, Scholtz C, Swash M. Post-encephalitic Parkinsonism: current experience. J Neurol Neurosurg Psychiatry 1981;44:670–676.
5. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta 2009;1792:714–721.
6. Willis AW, Sterling C, Racette BA. Conjugal parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism Relat Disord 2010;16:163–166.
7. Kohbata S, Beaman BL. L-DOPA-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice. Infect Immun 1991;59:181–191.
8. Hyland K, Beaman BL, LeWitt PA, DeMaggio AJ. Monoamine changes in the brain of BALB/c mice following sub-lethal infection with Nocardia asteroides (GUH-2). Neurochem Res 2000;25:443–448.
9. Camp DM, Loeffler DA, Razoky BA, Tam S, Beaman BL, LeWitt PA. Nocardia asteroides culture filtrates cause dopamine depletion and cytotoxicity in PC12 cells. Neurochem Res 2003;28:1359–1367.
10. Loeffler DA, Camp DM, Qu S, Beaman BL, LeWitt PA. Characterization of dopamine-depleting activity of Nocardia asteroides strain GUH-2 culture filtrate on PC12 cells. Microb Pathog 2004;37:73–85.
11. Chapman G, Beaman BL, Loeffler DA, et al. In situ hybridization for detection of nocardial 16S rRNA: reactivity within intracellular inclusions in experimentally infected cynomolgus monkeys—and in Lewy body-containing human brain specimens. Exp Neurol 2003;184:715–725.
12. Lu L, Camp DM, Loeffler DA, LeWitt PA. Lack of evidence for Nocardia asteroides in brain specimens from Lewy body-containing disorders. Microb Pathog 2005;39:205–211.
13. Dunnett SB, Iversen SD. Spontaneous and drug-induced rotation following localized 6-hydroxydopamine and kainic acid-induced lesions of the neostriatum. Neuropharmacology 1982;21:899–908.
14. Borlongan CV, Sanberg PR. Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J Neurosci 1995;15:5372–5378.
15. Jakowec MW, Petzinger GM. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Comp Med 2004;54:497–513.
16. Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 1984;224:1451–1453.
17. Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 2000;74:721–729.
18. Fornai F, Schlüter OM, Lenzi P, et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 2005;102:3413–3418.
19. Tieu K. A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med 2011;1:a009316.
20. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301–1306.
21. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002;277:1641–1644.
22. McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 2004;56:149–162.
23. Barry DP, Beaman BL. Nocardia asteroides strain GUH-2 induces proteasome inhibition and apoptotic death of cultured cells. Res Microbiol 2007;158:86–96.
24. Bernheimer H, Birkmayer W, Hornykiewicz 0, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 1973;20:415–455.
25. Gorrill RH, Heptinstall RH. The animal pathogenicity of Nocardia sebivorans nov. spec. J Pathol Bacteriol 1954;68:387–393.
26. Gorrill RH. Spinning disease of mice. J Pathol Bacteriol 1956;71:353–358.
27. Smith IM, Hayward AH. Nocardia caviae and Nocardia asteroides: comparative bacteriological and mouse pathogenicity studies. J Comp Pathol 1971;81:79–87.
28. Gorrill RH. Bacterial localisation in the kidney with particular reference to Pseudomonas pyocyanea. J Pathol Bacteriol 1952;64:857–864.
29. Saito H, Tasaka H. Comparison of the pathogenicity for mice of Mycobacterium fortuitum and Mycobacterium abscessus. J Bacteriol 1969;99:851–855.
30. Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson's disease: an update. J Parkinsons Dis 2011;1:19–33.
31. Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF. Selective alterations of gene expression in mice induced by MPTP. Synapse 2005;55:45–51.
32. Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003;110:517–536.
33. Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015;30:350–358.
34. Tsushima K, Koizumi T, Aoki H, Furuta K, Fujimoto K, Kubo K. A case of acute respiratory distress syndrome caused by systemic nocardiosis. Respiration 2000;67:591–592.
35. Dobbs RJ, Dobbs SM, Weller C, et al. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 2008;13:309–322.
36. Dow CT. M. paratuberculosis and Parkinson's disease—is this a trigger. Med Hypotheses 2014;83:709–712.
37. Filice GA, Beaman BL, Remington JS. Effects of activated macrophages on Nocardia asteroides. Infect Immun 1980;27:643–649.
38. Hubble JP, Cao T, Kjelstrom JA, Koller WC, Beaman BL. Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study. J Clin Microbiol 1995;33:2768–2769.
39. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043–1048.